Wearable Devices (WLDS) expands 2024 equity incentive plan share reserve

Rhea-AI Filing Summary

Wearable Devices Ltd. reported that its Board of Directors approved an increase in the number of ordinary shares reserved for its 2024 Global Equity Incentive Plan. The reserve rose by 1,431,713 shares, from 2,473,856 to 3,905,569 ordinary shares.

This change expands the pool of shares available for future equity-based awards to employees, directors, and other eligible participants under the plan. The report is also incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of March 2026

Commission file number: 001-41502

WEARABLE DEVICES Ltd.

(Translation of registrant’s name into English)

5 Ha-Tnufa Street

Yokne-am Illit, Israel 2066736

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F ☐

CONTENTS

On February 19, 2026, the Board of Directors of Wearable Devices Ltd. (the “Company”) approved an increase in the number of ordinary shares, no par value per share, of the Company reserved for issuance under the Company’s 2024 Global Equity Incentive Plan by 1,431,713 from 2,473,856 to 3,905,569.

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the registration statements on Form S-8  (File Nos. 333-291857, 333-290148, 333-284010, 333-269869 and 333-274343) and on Form F-3 (File Nos. 333-274841 and 333-291100) of the Company, filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Wearable Devices Ltd.
Date: March 2, 2026	By:	/s/ Asher Dahan
		Asher Dahan
		Chief Executive Officer

2

FAQ

What did Wearable Devices Ltd. (WLDS) change in its 2024 equity plan?

Wearable Devices Ltd. increased the share reserve under its 2024 Global Equity Incentive Plan. The pool rose by 1,431,713 ordinary shares, moving from 2,473,856 to 3,905,569 shares available for potential future equity awards.

How many shares are now reserved under Wearable Devices (WLDS) 2024 plan?

The 2024 Global Equity Incentive Plan now reserves 3,905,569 ordinary shares. This reflects an increase of 1,431,713 shares from the prior reserve of 2,473,856 shares, expanding capacity for stock-based compensation grants.

When did the Wearable Devices (WLDS) board approve the share reserve increase?

The Board of Directors approved the share reserve increase on February 19, 2026. This action formally raised the number of ordinary shares available under the 2024 Global Equity Incentive Plan for potential future awards to eligible participants.

Does this Wearable Devices (WLDS) 6-K affect existing SEC registration statements?

Yes. The Form 6-K is incorporated by reference into Wearable Devices’ existing registration statements on Form S-8 and Form F-3, making this update part of those filings unless later superseded by other submissions.

What type of shares are covered by Wearable Devices (WLDS) 2024 equity plan reserve?

The plan reserve consists of ordinary shares with no par value of Wearable Devices Ltd. These shares are designated for potential issuance as equity incentives to employees, directors, and other eligible service providers under the 2024 Global Equity Incentive Plan.

Who signed the Wearable Devices Ltd. (WLDS) Form 6-K related to the equity plan?

The Form 6-K was signed on behalf of Wearable Devices Ltd. by Asher Dahan, the company’s Chief Executive Officer. His signature confirms the company’s authorization and submission of the report describing the equity plan share reserve increase.